-Newsclick.in The recent agreements between Medicine Patent Pool and Big Pharma are being projected as benevolent gestures from pharma companies in sharing their patented technologies with other countries. The fact is it is working towards cementing its monopoly power further. The development of anti-viral oral pills to combat COVID-19 will, hopefully, make the fight against the pandemic more promising. While Merck has developed the anti-viral pill Molnupiravir, Pfizer has come up with...

-Newsclick.in It appears the stage is being set to scuttle India and South Africa’s IP waiver proposal with regard to Covid vaccines and technology ahead of the 12th WTO Ministerial this month-end. At various global fora, Big Pharma and rich countries have been steadfastly pushing the focus toward supply-side bottlenecks of vaccines and unequal distribution of doses in a bid to steer the discourse away from the more contentious issue of patents...

-The Indian Express Innovation in vaccine production can have an impact only if it is accessible to all. Patents and access to life-saving drugs has always been an emotive and contentious issue. The right to healthy life is a moral minimum, and to find a rational basis to deny it is deeply offensive to the idea of life itself. At the same time, pharma corporations and institutions claim patents are a just...

-The Hindu Over the last few decades, intellectual property rules have served as a lethal barrier to the right to access healthcare Even an unprecedented pandemic can do little, it appears, to upset the existing global regime governing monopoly rights over the production and distribution of life-saving drugs. If anything, since the onset of COVID-19, we’ve only seen a reaffirmation of intellectual property rules that have served as a lethal barrier to...

-The Hindu They seek waiver on some provisions of world agreements that regulate intellectual property rights to expedite steps to contain pandemic India and South Africa, in a formal submission to the World Trade Organization (WTO) on October 2, sought a waiver on certain provisions of the international agreements that regulate intellectual property rights to speed up efforts to prevent, treat and contain the COVID-19 pandemic. In the communication, the countries said there...